{"entity":{"type":"insider","cik":"0001438538","url":"/insider/0001438538","json_url":"/insider/0001438538.json","name":"Szyman Catherine M.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":93,"n_filings":62,"first":"2008-07-14","last":"2024-02-15","span_basis":"filed_date"},"name_variants":[{"name":"Szyman Catherine M.","source":"filing","n_filings":57,"first_seen":"2016-12-02","last_seen":"2024-02-15"},{"name":"Szyman Catherine M","source":"filing","n_filings":5,"first_seen":"2008-07-14","last_seen":"2014-04-21"}],"transactions":[{"id":2889891,"accession":"0001225208-24-002191","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001225208-24-002191","line_url":"/filing/0001225208-24-002191#line-4","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27000.0,"shares_display":"27,000","price_per_share":85.6168,"price_display":"85.62","price_state":"stated","total_value":2311653.6,"total_display":"2,311,653.60","total_whole":"2,311,654","shares_owned_after":34813.571,"shares_owned_after_display":"34,813.57","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-15","filed_date":"2024-02-15","scope":"insider"},{"id":2889882,"accession":"0001225208-24-002191","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-24-002191","line_url":"/filing/0001225208-24-002191#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":86.46,"price_display":"86.46","price_state":"stated","total_value":1729200.0,"total_display":"1,729,200.00","total_whole":"1,729,200","shares_owned_after":34813.571,"shares_owned_after_display":"34,813.57","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-13","filed_date":"2024-02-15","scope":"insider"},{"id":8683105,"accession":"0001225208-23-009461","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-23-009461","line_url":"/filing/0001225208-23-009461#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":72.68,"price_display":"72.68","price_state":"stated","total_value":363400.0,"total_display":"363,400.00","total_whole":"363,400","shares_owned_after":34813.571,"shares_owned_after_display":"34,813.57","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-10","filed_date":"2023-10-10","scope":"insider"},{"id":7905888,"accession":"0001225208-23-008819","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-23-008819","line_url":"/filing/0001225208-23-008819#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":76.0,"price_display":"76.00","price_state":"stated","total_value":380000.0,"total_display":"380,000.00","total_whole":"380,000","shares_owned_after":34813.571,"shares_owned_after_display":"34,813.57","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-08","filed_date":"2023-09-08","scope":"insider"},{"id":8004631,"accession":"0001225208-23-008138","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-23-008138","line_url":"/filing/0001225208-23-008138#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":78.637,"price_display":"78.64","price_state":"stated","total_value":393185.0,"total_display":"393,185.00","total_whole":"393,185","shares_owned_after":34813.571,"shares_owned_after_display":"34,813.57","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-09","filed_date":"2023-08-09","scope":"insider"},{"id":8342746,"accession":"0001225208-23-007434","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-23-007434","line_url":"/filing/0001225208-23-007434#line-3","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":90.52,"price_display":"90.52","price_state":"stated","total_value":452600.0,"total_display":"452,600.00","total_whole":"452,600","shares_owned_after":34813.571,"shares_owned_after_display":"34,813.57","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-10","filed_date":"2023-07-10","scope":"insider"},{"id":8229283,"accession":"0001225208-23-006806","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-23-006806","line_url":"/filing/0001225208-23-006806#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":85.809,"price_display":"85.81","price_state":"stated","total_value":429045.0,"total_display":"429,045.00","total_whole":"429,045","shares_owned_after":35055.7795,"shares_owned_after_display":"35,055.78","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-13","filed_date":"2023-06-13","scope":"insider"},{"id":8414119,"accession":"0001225208-23-005616","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001225208-23-005616","line_url":"/filing/0001225208-23-005616#line-5","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75600.0,"shares_display":"75,600","price_per_share":88.9449,"price_display":"88.94","price_state":"stated","total_value":6724234.44,"total_display":"6,724,234.44","total_whole":"6,724,234","shares_owned_after":28530.7795,"shares_owned_after_display":"28,530.78","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-09","filed_date":"2023-05-09","scope":"insider"},{"id":6678395,"accession":"0001225208-22-006584","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001225208-22-006584","line_url":"/filing/0001225208-22-006584","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23400.0,"shares_display":"23,400","price_per_share":104.86443206837608,"price_display":"104.86","price_state":"stated","total_value":2453827.7104,"total_display":"2,453,827.71","total_whole":"2,453,828","shares_owned_after":30850.6569,"shares_owned_after_display":"30,850.66","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-04","filed_date":"2022-05-05","scope":"insider","n_lines":3},{"id":6994735,"accession":"0001225208-22-005751","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001225208-22-005751","line_url":"/filing/0001225208-22-005751","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":122.040685505,"price_display":"122.04","price_state":"stated","total_value":2440813.7101,"total_display":"2,440,813.71","total_whole":"2,440,814","shares_owned_after":27568.6569,"shares_owned_after_display":"27,568.66","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-11","filed_date":"2022-04-11","scope":"insider","n_lines":3},{"id":6337743,"accession":"0001225208-22-004663","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-22-004663","line_url":"/filing/0001225208-22-004663","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":104.650036535,"price_display":"104.65","price_state":"stated","total_value":2093000.7307,"total_display":"2,093,000.73","total_whole":"2,093,001","shares_owned_after":27414.5223,"shares_owned_after_display":"27,414.52","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-14","filed_date":"2022-03-14","scope":"insider","n_lines":2},{"id":6964842,"accession":"0001225208-22-002824","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-22-002824","line_url":"/filing/0001225208-22-002824","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":106.312631,"price_display":"106.31","price_state":"stated","total_value":2126252.62,"total_display":"2,126,252.62","total_whole":"2,126,253","shares_owned_after":27414.5223,"shares_owned_after_display":"27,414.52","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-18","filed_date":"2022-02-18","scope":"insider","n_lines":2},{"id":6380039,"accession":"0001225208-22-000769","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-22-000769","line_url":"/filing/0001225208-22-000769","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":119.52632332,"price_display":"119.53","price_state":"stated","total_value":1195263.2332,"total_display":"1,195,263.23","total_whole":"1,195,263","shares_owned_after":27414.5223,"shares_owned_after_display":"27,414.52","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-14","filed_date":"2022-01-14","scope":"insider","n_lines":2},{"id":4543270,"accession":"0001225208-21-015136","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-21-015136","line_url":"/filing/0001225208-21-015136#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":121.24,"price_display":"121.24","price_state":"stated","total_value":1212400.0,"total_display":"1,212,400.00","total_whole":"1,212,400","shares_owned_after":27414.5223,"shares_owned_after_display":"27,414.52","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-17","filed_date":"2021-12-17","scope":"insider"},{"id":5411471,"accession":"0001225208-21-013981","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001225208-21-013981","line_url":"/filing/0001225208-21-013981","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":117.79276895,"price_display":"117.79","price_state":"stated","total_value":1177927.6895,"total_display":"1,177,927.69","total_whole":"1,177,928","shares_owned_after":27414.5223,"shares_owned_after_display":"27,414.52","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-18","filed_date":"2021-11-19","scope":"insider","n_lines":3},{"id":4192024,"accession":"0001225208-21-013132","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-21-013132","line_url":"/filing/0001225208-21-013132","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9741.0,"shares_display":"9,741","price_per_share":110.4077241864285,"price_display":"110.41","price_state":"stated","total_value":1075481.6413,"total_display":"1,075,481.64","total_whole":"1,075,482","shares_owned_after":27414.5223,"shares_owned_after_display":"27,414.52","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-18","filed_date":"2021-10-18","scope":"insider","n_lines":2},{"id":4639500,"accession":"0001225208-21-012145","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-21-012145","line_url":"/filing/0001225208-21-012145#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9741.0,"shares_display":"9,741","price_per_share":121.2773,"price_display":"121.28","price_state":"stated","total_value":1181362.1793,"total_display":"1,181,362.18","total_whole":"1,181,362","shares_owned_after":27414.5223,"shares_owned_after_display":"27,414.52","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-08","filed_date":"2021-09-08","scope":"insider"},{"id":4906874,"accession":"0001225208-21-011037","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-21-011037","line_url":"/filing/0001225208-21-011037#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":113.5269,"price_display":"113.53","price_state":"stated","total_value":1702903.5,"total_display":"1,702,903.50","total_whole":"1,702,904","shares_owned_after":27758.9088,"shares_owned_after_display":"27,758.91","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-02","filed_date":"2021-08-02","scope":"insider"},{"id":5124506,"accession":"0001225208-21-009449","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-21-009449","line_url":"/filing/0001225208-21-009449#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3410.0,"shares_display":"3,410","price_per_share":101.17,"price_display":"101.17","price_state":"stated","total_value":344989.7,"total_display":"344,989.70","total_whole":"344,990","shares_owned_after":27704.7936,"shares_owned_after_display":"27,704.79","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-15","filed_date":"2021-06-15","scope":"insider"},{"id":4116018,"accession":"0001225208-21-008675","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-21-008675","line_url":"/filing/0001225208-21-008675#line-1","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2061.0,"shares_display":"2,061","price_per_share":95.29,"price_display":"95.29","price_state":"stated","total_value":196392.69,"total_display":"196,392.69","total_whole":"196,393","shares_owned_after":27704.7936,"shares_owned_after_display":"27,704.79","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-28","filed_date":"2021-05-28","scope":"insider"},{"id":4296778,"accession":"0001225208-21-008560","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-21-008560","line_url":"/filing/0001225208-21-008560#line-1","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4665.4212,"shares_display":"4,665.42","price_per_share":96.09,"price_display":"96.09","price_state":"stated","total_value":448300.323108,"total_display":"448,300.32","total_whole":"448,300","shares_owned_after":29765.7936,"shares_owned_after_display":"29,765.79","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-25","filed_date":"2021-05-25","scope":"insider"},{"id":5064199,"accession":"0001225208-21-007763","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-21-007763","line_url":"/filing/0001225208-21-007763#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3389.0,"shares_display":"3,389","price_per_share":91.87,"price_display":"91.87","price_state":"stated","total_value":311347.43,"total_display":"311,347.43","total_whole":"311,347","shares_owned_after":30940.2148,"shares_owned_after_display":"30,940.21","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-07","filed_date":"2021-05-07","scope":"insider"},{"id":5211127,"accession":"0001225208-21-006929","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-21-006929","line_url":"/filing/0001225208-21-006929#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3389.0,"shares_display":"3,389","price_per_share":94.4,"price_display":"94.40","price_state":"stated","total_value":319921.6,"total_display":"319,921.60","total_whole":"319,922","shares_owned_after":26966.0572,"shares_owned_after_display":"26,966.06","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-22","filed_date":"2021-04-22","scope":"insider"},{"id":5350871,"accession":"0001225208-21-005358","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-21-005358","line_url":"/filing/0001225208-21-005358#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3389.0,"shares_display":"3,389","price_per_share":81.66,"price_display":"81.66","price_state":"stated","total_value":276745.74,"total_display":"276,745.74","total_whole":"276,746","shares_owned_after":26746.1397,"shares_owned_after_display":"26,746.14","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-15","scope":"insider"},{"id":4851582,"accession":"0001225208-21-002568","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-21-002568","line_url":"/filing/0001225208-21-002568#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3389.0,"shares_display":"3,389","price_per_share":88.2,"price_display":"88.20","price_state":"stated","total_value":298909.8,"total_display":"298,909.80","total_whole":"298,910","shares_owned_after":26746.1397,"shares_owned_after_display":"26,746.14","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-16","scope":"insider"},{"id":4393511,"accession":"0001225208-21-000866","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-21-000866","line_url":"/filing/0001225208-21-000866#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3389.0,"shares_display":"3,389","price_per_share":87.27,"price_display":"87.27","price_state":"stated","total_value":295758.03,"total_display":"295,758.03","total_whole":"295,758","shares_owned_after":26746.1397,"shares_owned_after_display":"26,746.14","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-15","scope":"insider"},{"id":2303607,"accession":"0001225208-20-012815","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-20-012815","line_url":"/filing/0001225208-20-012815#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20355.0,"shares_display":"20,355","price_per_share":73.2441,"price_display":"73.24","price_state":"stated","total_value":1490883.6555,"total_display":"1,490,883.66","total_whole":"1,490,884","shares_owned_after":26746.1397,"shares_owned_after_display":"26,746.14","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-29","filed_date":"2020-10-29","scope":"insider"},{"id":2810968,"accession":"0001225208-20-010598","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-20-010598","line_url":"/filing/0001225208-20-010598#line-1","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2249.0,"shares_display":"2,249","price_per_share":78.24,"price_display":"78.24","price_state":"stated","total_value":175961.76,"total_display":"175,961.76","total_whole":"175,962","shares_owned_after":26746.1397,"shares_owned_after_display":"26,746.14","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-13","filed_date":"2020-08-13","scope":"insider"},{"id":2842847,"accession":"0001225208-20-009740","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-20-009740","line_url":"/filing/0001225208-20-009740#line-1","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2249.0,"shares_display":"2,249","price_per_share":67.66,"price_display":"67.66","price_state":"stated","total_value":152167.34,"total_display":"152,167.34","total_whole":"152,167","shares_owned_after":28995.1397,"shares_owned_after_display":"28,995.14","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-14","filed_date":"2020-07-14","scope":"insider"},{"id":2915862,"accession":"0001225208-20-009021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-20-009021","line_url":"/filing/0001225208-20-009021#line-1","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3348.0,"shares_display":"3,348","price_per_share":70.67,"price_display":"70.67","price_state":"stated","total_value":236603.16,"total_display":"236,603.16","total_whole":"236,603","shares_owned_after":31215.6694,"shares_owned_after_display":"31,215.67","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-16","filed_date":"2020-06-16","scope":"insider"},{"id":3327576,"accession":"0001225208-20-008853","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-20-008853","line_url":"/filing/0001225208-20-008853#line-1","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2249.0,"shares_display":"2,249","price_per_share":72.59,"price_display":"72.59","price_state":"stated","total_value":163254.91,"total_display":"163,254.91","total_whole":"163,255","shares_owned_after":34563.6694,"shares_owned_after_display":"34,563.67","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-11","filed_date":"2020-06-11","scope":"insider"},{"id":2832009,"accession":"0001209191-20-032418","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-032418","line_url":"/filing/0001209191-20-032418#line-1","is_derivative":false,"issuer_cik":"0001438538","issuer_name":"Inari Medical, Inc.","issuer_ticker":"NARI","issuer_name_source":null,"issuer_url":"/issuer/0001438538","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":28091.0,"shares_display":"28,091","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":533729.0,"total_display":"533,729.00","total_whole":"533,729","shares_owned_after":28091.0,"shares_owned_after_display":"28,091","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-27","filed_date":"2020-05-27","scope":"insider"},{"id":2228890,"accession":"0001225208-20-007661","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-20-007661","line_url":"/filing/0001225208-20-007661#line-1","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1116.0,"shares_display":"1,116","price_per_share":212.69,"price_display":"212.69","price_state":"stated","total_value":237362.04,"total_display":"237,362.04","total_whole":"237,362","shares_owned_after":12270.8898,"shares_owned_after_display":"12,270.89","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-14","filed_date":"2020-05-14","scope":"insider"},{"id":2600215,"accession":"0001225208-20-007628","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001225208-20-007628","line_url":"/filing/0001225208-20-007628#line-5","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":216.93,"price_display":"216.93","price_state":"stated","total_value":162697.5,"total_display":"162,697.50","total_whole":"162,698","shares_owned_after":13386.8898,"shares_owned_after_display":"13,386.89","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-13","filed_date":"2020-05-13","scope":"insider"},{"id":2195247,"accession":"0001225208-20-006509","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-20-006509","line_url":"/filing/0001225208-20-006509#line-1","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1116.0,"shares_display":"1,116","price_per_share":216.91,"price_display":"216.91","price_state":"stated","total_value":242071.56,"total_display":"242,071.56","total_whole":"242,072","shares_owned_after":14754.8898,"shares_owned_after_display":"14,754.89","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-16","filed_date":"2020-04-16","scope":"insider"},{"id":3211598,"accession":"0001225208-20-005482","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-20-005482","line_url":"/filing/0001225208-20-005482#line-1","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1116.0,"shares_display":"1,116","price_per_share":162.95,"price_display":"162.95","price_state":"stated","total_value":181852.2,"total_display":"181,852.20","total_whole":"181,852","shares_owned_after":15773.2167,"shares_owned_after_display":"15,773.22","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-23","filed_date":"2020-03-23","scope":"insider"},{"id":2481472,"accession":"0001225208-20-002681","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-20-002681","line_url":"/filing/0001225208-20-002681#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":228.57,"price_display":"228.57","price_state":"stated","total_value":571425.0,"total_display":"571,425.00","total_whole":"571,425","shares_owned_after":16889.2167,"shares_owned_after_display":"16,889.22","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-18","filed_date":"2020-02-18","scope":"insider"},{"id":2051598,"accession":"0001225208-20-001530","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-20-001530","line_url":"/filing/0001225208-20-001530#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":219.5,"price_display":"219.50","price_state":"stated","total_value":548750.0,"total_display":"548,750.00","total_whole":"548,750","shares_owned_after":16889.2167,"shares_owned_after_display":"16,889.22","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-03","filed_date":"2020-02-03","scope":"insider"},{"id":7930873,"accession":"0001225208-19-015846","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-19-015846","line_url":"/filing/0001225208-19-015846#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":234.2746,"price_display":"234.27","price_state":"stated","total_value":585686.5,"total_display":"585,686.50","total_whole":"585,687","shares_owned_after":17104.8134,"shares_owned_after_display":"17,104.81","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-16","filed_date":"2019-12-16","scope":"insider"},{"id":8361975,"accession":"0001225208-19-014593","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-19-014593","line_url":"/filing/0001225208-19-014593#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0001438538","owner_name":"Szyman Catherine M.","owner_display_name":"Szyman Catherine M.","owner_url":"/insider/0001438538","role":"Officer (CVP, Critical Care)","role_mark":"O","role_mark_label":"Officer (CVP, Critical Care)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, Critical Care","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":242.14,"price_display":"242.14","price_state":"stated","total_value":605350.0,"total_display":"605,350.00","total_whole":"605,350","shares_owned_after":17104.8134,"shares_owned_after_display":"17,104.81","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-15","filed_date":"2019-11-15","scope":"insider"}],"collapsed":true,"next_cursor":"2019-11-15|8361975","ledger_fault":false,"count":{"value":93,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":90,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":93},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001099800","name":"Edwards Lifesciences Corp","url":"/issuer/0001099800","role":"Officer (CVP, Critical Care)","n_filings":56,"first_seen":"2016-12-02","last_seen":"2024-02-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001531048","name":"Inari Medical, Inc.","url":"/issuer/0001531048","role":"Director","n_filings":1,"first_seen":"2020-05-27","last_seen":"2020-05-27"},{"type":"issuer","type_label":"ISSUER","cik":"0000064670","name":"MEDTRONIC INC","url":"/issuer/0000064670","role":"Officer (SrVP & Pres Diabetes)","n_filings":5,"first_seen":"2008-07-14","last_seen":"2014-04-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001438538","retrieved_at":"2026-08-23T12:00:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}